Abstract | BACKGROUND/AIMS: We have previously shown that long-term consumption of 10% beef tallow diet promotes colon carcinogenesis in both saline- and azoxymethane (AOM)-treated rats. Here, we investigated the effects of mofezolac, a selective COX-1 inhibitor, on beef tallow-fed rats with saline- or AOM treatment. METHODOLOGY: Male SD rats were intraperitoneally injected with saline or AOM and fed 10% beef tallow diet with or without 1200 ppm mofezolac. At 12 weeks, aberrant crypt foci (ACF) were examined. At 44 weeks, tumors were counted, the proliferation and expression of COX-1 and 8-catenin on normal-appearing colonic mucosa was evaluated using the BrdU incorporation assay and Western blotting respectively. RESULTS:
Mofezolac decreased the number of ACF at 12 weeks (p < 0.05) and reduced tumor multiplicity and incidence at 44 weeks in beef tallow-fed rats with AOM treatment (p < 0.05). At 44 weeks, reduction of the BrdU-positive cells (p < 0.05) and beneficial distribution changes of these cells within the colon crypts in both groups with mofezolac supplementation were observed. The expression of COX-1 and beta-catenin also reduced in mofezolac-added groups simultaneously (p < 0.05). CONCLUSIONS:
|
Authors | Lujie Miao, Ryosuke Shiraishi, Takehiro Fujise, Tsukasa Kuroki, Takashi Kakimoto, Yasuhisa Sakata, Tooru Takashima, Ryuichi Iwakiri, Kazuma Fujimoto, Ruihua Shi, Xueliang Li |
Journal | Hepato-gastroenterology
(Hepatogastroenterology)
2011 Jan-Feb
Vol. 58
Issue 105
Pg. 81-8
ISSN: 0172-6390 [Print] Greece |
PMID | 21510291
(Publication Type: Journal Article)
|
Chemical References |
- Dietary Fats
- Fats
- Isoxazoles
- tallow
- Azoxymethane
- mofezolac
|
Topics |
- Animals
- Azoxymethane
(toxicity)
- Blotting, Western
- Cattle
- Cell Proliferation
(drug effects)
- Chi-Square Distribution
- Colonic Neoplasms
(etiology, prevention & control)
- Dietary Fats
(toxicity)
- Fats
- Isoxazoles
(administration & dosage, pharmacology)
- Male
- Rats
- Rats, Sprague-Dawley
|